Literature DB >> 10751399

HIV-1 reverse transcriptase-pseudoknot RNA aptamer interaction has a binding affinity in the low picomolar range coupled with high specificity.

O Kensch1, B A Connolly, H J Steinhoff, A McGregor, R S Goody, T Restle.   

Abstract

Systematic evolution of ligands by exponential enrichment (SELEX) is a powerful method for the identification of small oligonucleotides that bind with high affinity and specificity to target proteins. Such DNAs/RNAs are a new class of potential chemotherapeutics that could block the enzymatic activity of pathologically relevant proteins. We have conducted a detailed biochemical study of the interaction of human immunodeficiency virus 1 (HIV-1) reverse transcriptase (RT) with a SELEX-derived pseudoknot RNA aptamer. Electron paramagnetic resonance spectroscopy of site-directed spin-labeled RT mutants revealed that this aptamer was selected for binding to the "closed" conformation of the enzyme. Kinetic analysis showed that the RNA inhibitor bound to HIV RT in a two-step process, with association rates similar to those described for model DNA/DNA and DNA/RNA substrates. However, the dissociation of the pseudoknot RNA from RT was dramatically slower than observed for model substrates. Equilibrium binding studies revealed an extraordinarily low K(d), of about 25 pm, for the enzyme-aptamer interaction, presumably a consequence of the slow off-rates. Additionally, this pseudoknot aptamer is highly specific for HIV-1 RT, with the closely related HIV-2 enzyme showing a binding affinity close to 4 orders of magnitude lower.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751399     DOI: 10.1074/jbc.M001309200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Time-resolved detection of transient movement of helices F and G in doubly spin-labeled bacteriorhodopsin.

Authors:  N Radzwill; K Gerwert; H J Steinhoff
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

2.  Inhibition of HIV-1 reverse transcriptase by RNA aptamers in Escherichia coli.

Authors:  David G Nickens; James T Patterson; Donald H Burke
Journal:  RNA       Date:  2003-09       Impact factor: 4.942

3.  Novel aptamer inhibitors of human immunodeficiency virus reverse transcriptase.

Authors:  Jeffrey J DeStefano; Gauri R Nair
Journal:  Oligonucleotides       Date:  2008-06

Review 4.  Approaches for measuring the dynamics of RNA-protein interactions.

Authors:  Donny D Licatalosi; Xuan Ye; Eckhard Jankowsky
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-08-20       Impact factor: 9.957

Review 5.  Methods for measuring aptamer-protein equilibria: a review.

Authors:  Meng Jing; Michael T Bowser
Journal:  Anal Chim Acta       Date:  2010-11-10       Impact factor: 6.558

6.  Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1.

Authors:  Laurent Chaloin; Maik Jörg Lehmann; Georg Sczakiel; Tobias Restle
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

7.  Multiparameter single-molecule fluorescence spectroscopy reveals heterogeneity of HIV-1 reverse transcriptase:primer/template complexes.

Authors:  P J Rothwell; S Berger; O Kensch; S Felekyan; M Antonik; B M Wöhrl; T Restle; R S Goody; C A M Seidel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

8.  SELEX-derived aptamers of the duck hepatitis B virus RNA encapsidation signal distinguish critical and non-critical residues for productive initiation of reverse transcription.

Authors:  Kanghong Hu; Jürgen Beck; Michael Nassal
Journal:  Nucleic Acids Res       Date:  2004-08-16       Impact factor: 16.971

9.  Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).

Authors:  Pheroze Joshi; Vinayaka R Prasad
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Design principles for riboswitch function.

Authors:  Chase L Beisel; Christina D Smolke
Journal:  PLoS Comput Biol       Date:  2009-04-17       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.